HomeInsightsPE

Auro Laboratories Ltd PE Ratio

Auro Laboratories Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

5.6 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Auro Laboratories Ltd

NSE: AUROLABS

PE

20.2

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Auro Laboratories Ltd is 20.2 as of 23 Nov 13:12 PM .
  • The P/E Ratio of Auro Laboratories Ltd changed from 8.4 on March 2019 to 12.9 on March 2024 . This represents a CAGR of 7.41% over 6 years.
  • The Latest Trading Price of Auro Laboratories Ltd is ₹ 199.6 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Auro Laboratories Ltd

No data available

Company Fundamentals for Auro Laboratories Ltd

No data available

Image

Auro Laboratories Ltd

NSE: AUROLABS

Share Price

₹ 199.6

4.15 (2.12%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Auro Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Auro Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024199.6
21 Nov 2024195.45
19 Nov 2024199
18 Nov 2024208.3
14 Nov 2024199
13 Nov 2024208
12 Nov 2024230.85
11 Nov 2024256.5
08 Nov 2024245.7
07 Nov 2024253.75

SWOT Analysis Of Auro Laboratories Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Auro Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Auro Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Auro Laboratories Ltd20124
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Auro Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Auro Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Auro Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Auro Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Auro Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Auro Laboratories Ltd

No data available

* All values are in %

About Auro Laboratories Ltd

  • Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API).
  • Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes.
  • The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
  • The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
  • Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments.

Auro Laboratories Ltd News Hub

News

Auro Laboratories standalone net profit rises 5.63% in the June 2024 quarter

Net profit of Auro Laboratories rose 5.63% to Rs 0.75 crore in the quarter ended June 2024...

Read more

2024-08-10 00:00:00

News

Auro Laboratories to announce Quarterly Result

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 9 August...

Read more

2024-08-01 00:00:00

News

Auro Laboratories to hold board meeting

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 11 Novem...

Read more

2024-11-06 00:00:00

News

Auro Laboratories standalone net profit declines 81.73% in the September 2024 quarter

Net profit of Auro Laboratories declined 81.73% to Rs 0.36 crore in the quarter ended Sept...

Read more

2024-11-12 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Auro Laboratories Ltd

What is the current PE Ratio of Auro Laboratories Ltd?

The Current PE Ratio of Auro Laboratories Ltd is 20.16 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of Auro Laboratories Ltd last year?

The PE Ratio of Auro Laboratories Ltd was 13.94 last year, now the PE ratio is 20.16, showing a year-on-year growth of 44.6%.

What does the PE Ratio of Auro Laboratories Ltd indicate about its stock?

The PE Ratio of Auro Laboratories Ltd is 20.16. This ratio indicates that investors are willing to pay 20.16 times the earnings per share for each share of Auro Laboratories Ltd.

What is the PE Ratio Growth of Auro Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Auro Laboratories Ltd grew by 44.6% whereas, the EPS ratio grew by -52.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*